We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
CDW
CDW
$17.1B
| $2.91M | 0.03% |
+70,128
| New | +$2.73M |
|
477
Chipotle Mexican Grill
CMG
$40.8B
| $2.89M | 0.03% |
306,850
+198,550
| +183% | +$1.89M |
|
478
Sasol
SSL
$7.58B
| $2.88M | 0.03% |
+97,570
| New | +$2.65M |
|
|
FIT
479
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $2.88M | 0.03% |
+189,993
| New | +$3.02M |
|
|
PFNX
480
DELISTED
Pfenex Inc.
PFNX
| $2.88M | 0.03% |
292,445
| – | – |
|
481
Kaiser Aluminum
KALU
$2.67B
| $2.86M | 0.03% |
+33,880
| New | +$2.66M |
|
482
Skywest
SKYW
$4.11B
| $2.85M | 0.03% |
142,729
-614,096
| -81% | -$10.4M |
|
483
Chunghwa Telecom
CHT
$33.2B
| $2.83M | 0.03% |
+83,849
| New | +$2.65M |
|
484
ConocoPhillips
COP
$147B
| $2.83M | 0.03% |
70,274
-30,262
| -30% | -$1.15M |
|
|
CAVM
485
DELISTED
Cavium, Inc.
CAVM
| $2.78M | 0.03% |
+45,462
| New | +$2.62M |
|
486
IMAX
IMAX
$2.38B
| $2.78M | 0.03% |
89,328
+50,420
| +130% | +$1.54M |
|
487
RPC Inc
RES
$1.24B
| $2.77M | 0.03% |
+195,289
| New | +$2.48M |
|
488
RH
RH
$3.3B
| $2.77M | 0.03% |
66,007
+23,738
| +56% | +$1.21M |
|
489
Ryder
R
$10.3B
| $2.75M | 0.03% |
42,426
-86,976
| -67% | -$4.94M |
|
490
Snap-on
SNA
$20.9B
| $2.74M | 0.03% |
+17,460
| New | +$2.67M |
|
491
Caleres
CAL
$396M
| $2.71M | 0.03% |
95,944
+66,583
| +227% | +$1.77M |
|
|
BXLT
492
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $2.69M | 0.03% |
66,610
+32,553
| +96% | +$1.29M |
|
|
SCS
493
DELISTED
Steelcase
SCS
| $2.67M | 0.03% |
+178,787
| New | +$2.38M |
|
494
Transocean
RIG
$5.92B
| $2.66M | 0.03% |
291,224
-90,902
| -24% | -$904K |
|
495
First American
FAF
$7.67B
| $2.63M | 0.03% |
+68,897
| New | +$2.45M |
|
|
VMW
496
DELISTED
VMware, Inc
VMW
| $2.61M | 0.03% |
49,911
-117,034
| -70% | -$5.8M |
|
|
BWP
497
DELISTED
Boardwalk Pipeline Partners
BWP
| $2.61M | 0.03% |
+176,913
| New | +$2.16M |
|
498
Armstrong World Industries
AWI
$6.86B
| $2.61M | 0.03% |
+53,888
| New | +$2.21M |
|
|
PTLA
499
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.59M | 0.03% |
127,057
-836,467
| -87% | -$26.5M |
|
500
Capital One
COF
$124B
| $2.59M | 0.03% |
37,372
-168,409
| -82% | -$11.1M |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.